ECSP982492A - POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIED - Google Patents
POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIEDInfo
- Publication number
- ECSP982492A ECSP982492A ECSP982492A ECSP982492A EC SP982492 A ECSP982492 A EC SP982492A EC SP982492 A ECSP982492 A EC SP982492A EC SP982492 A ECSP982492 A EC SP982492A
- Authority
- EC
- Ecuador
- Prior art keywords
- modified
- polyethylene glycol
- interferon therapy
- glycol interferon
- therapy
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Se revela un método que comprende la administarción de un PEG12000-IFN alfa conjugado a un individuo que padece una infección viral, preferentemente hepatitis crónica C, susceptible de un tratamiento con interferón alfa.A method is disclosed comprising administering a conjugated PEG12000-IFN alpha to an individual suffering from a viral infection, preferably chronic hepatitis C, susceptible to treatment with interferon alpha.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP982492 ECSP982492A (en) | 1998-04-29 | 1998-04-29 | POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIED |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP982492 ECSP982492A (en) | 1998-04-29 | 1998-04-29 | POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIED |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP982492A true ECSP982492A (en) | 1999-01-26 |
Family
ID=42043413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP982492 ECSP982492A (en) | 1998-04-29 | 1998-04-29 | POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIED |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP982492A (en) |
-
1998
- 1998-04-29 EC ECSP982492 patent/ECSP982492A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9809425A (en) | Alpha interferon-polyethylene glycol conjugates for infection therapy | |
EA199800674A1 (en) | METHOD OF REPEATED TREATMENT OF PATIENTS WITH HEPATITIS C | |
BR0009840A (en) | Combination therapy for hcv, containing ribavirin in combination with antioxidants | |
MD990258A (en) | Method of treatment of the acute viral hepatitis B | |
ES2181502T3 (en) | TREATMENT OF HEPATITIS B INFECTION WITH ALFA 1 TIMOSINE AND LAMIVUDINE. | |
ECSP982492A (en) | POLYETHYLENE GLYCOL INTERFERON THERAPY, MODIFIED | |
PT1077683E (en) | ANTI-DEPRESSIVE THERAPY | |
DK0687181T3 (en) | Method of treating hepatitis C in individuals who do not respond to interferon therapy | |
DE50204475D1 (en) | PREPARATIONS OF VITAMIN E IN COMBINATION WITH AFAMINE | |
CY1106388T1 (en) | THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN | |
SE9602262D0 (en) | New use of cystine derivatives | |
DE60045663D1 (en) | RICH INTERFERON ALPHA | |
ATE237616T1 (en) | USE OF (1R,4S)-4-(6-AMINO-9H-PURINE-9-YL)-2-CYCLOPENT-1-METHANOL IN HBV | |
DK1311286T3 (en) | Treatment of hepatitis C with thymosin and pegylated interferon | |
UA43389C2 (en) | METHOD OF REDUCING SERUM CALCIUM LEVELS | |
EA199800818A1 (en) | Method of treating insomnia | |
ECSP993178A (en) | COMBINATORY THERAPY WITH RIBARVIRINE-INTERFERON ALPHA TO ERADICATE HCV-DETECTABLE RNA IN THOSE PATIENTS WITH CHRONIC HEPATITIS C INFECTION | |
RS53223B (en) | Methods and mixtures for treatment of viral hepatitis c |